Carbamazepine price in the Philippines
Quick answer
The DOH reference price for carbamazepine 200 mg tablet is ₱2.25 per tablet (median, June 2024 index); drugstore prices are usually higher. FDA Philippines lists 31 registered carbamazepine products (checked 2026-11-05): 6 as unbranded generics and 25 under 23 brand names. It is a prescription (Rx) medicine. Ask the pharmacist for the unbranded generic of the same strength; it is on the FDA VAT-exempt list, so no 12% VAT applies.
Government reference price
At the DOH median, 30 tablets cost about ₱67.50, a month at one a day.
DPRI range, DOH DPRI June 2024. What public hospitals pay; drugstore prices are usually higher.
Strengths
Carbamazepine by strength
Carbamazepine is listed here in 3 strengths; 3 of them (100 mg, 200 mg, 400 mg) have FDA-registered products in the Philippines.
| Strength | DOH median (₱) | FDA products |
|---|---|---|
| Carbamazepine 100 mg | – | 1 |
| Carbamazepine 200 mg | ₱2.25 | 24 |
| Carbamazepine 400 mg | – | 6 |
Sources: FDA Philippines registry (2026-11-05), DOH DPRI June 2024.
About carbamazepine
Used for
Carbamazepine is a seizure medicine. The US FDA label for carbamazepine tablets lists two uses:
- epilepsy, including partial seizures with complex symptoms, generalized tonic-clonic (grand mal) seizures and mixed seizure types
- the nerve pain of true trigeminal neuralgia, a sharp pain in the face
It does not appear to control absence (petit mal) seizures. It is not meant for minor aches.
How it works
The label says its exact mechanism is unknown. In animal studies it reduced the spread of nerve signals that trigger seizures and blocked pain from a facial nerve.
How to take it and usual dose
Take it with meals. The dose starts low and goes up slowly. For epilepsy in adults and children over 12, the usual start is 200 mg twice a day. It is raised weekly, spread over three or four doses, to a usual maintenance of 800 to 1,200 mg a day. For trigeminal neuralgia, the first day is 100 mg twice a day. Children's doses are lower and based on age or weight. Stopping suddenly can bring on seizures. Your doctor decides the dose.
Do not use if
- you have had bone marrow suppression before
- you are allergic to carbamazepine or to tricyclic medicines such as amitriptyline or imipramine
- you take nefazodone
- you have taken an MAO inhibitor in the last 14 days
Common side effects
At the start, the most frequent are dizziness, drowsiness, unsteadiness, nausea and vomiting.
The US label carries a boxed warning about two rare but serious risks. The first is severe skin reactions (SJS and TEN), which are linked to a gene variant called HLA-B*1502. The label notes this variant is common in parts of Asia, including parts of the Philippines, and advises a gene test first in at-risk groups. The second is a severe drop in blood cells (aplastic anemia, agranulocytosis). Stop and see a doctor at the first sign of a rash.
Source: US FDA label (DailyMed), 2026-06-29. A summary of the official label, not medical advice: your doctor or pharmacist knows your case.
Registered products
Registered carbamazepine products
FDA Philippines lists 31 registrations under 24 brand names (one row is unbranded generics).
| Brand | Strength and form | Class | Manufacturer | Reg. |
|---|---|---|---|---|
| Carbaglob 200 | 200 mg Tablet | Rx | Globela Pharma Private Limited (India) | 1 |
| Carbamal-400 CR | 400 mg Extended Release Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 1 |
| Carbastal | 200 mg Tablet | Rx | Stallion Laboratories Pvt. Ltd (India) | 1 |
| Carbazedin | 200 mg Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 1 |
| Carbazedin ER | 200 mg Extended-Release Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 1 |
| Carbezin | 200mg Tablet | Rx | Psychotropics India, Ltd. (India) | 1 |
| Carbilepp | 200 mg Tablet | Rx | Medochemie Ltd (Cyprus) | 1 |
| Carbitol-200 ER | 200 mg Extended Release Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 1 |
Show 16 more brands
Registered carbamazepine products, continued
| Brand | Strength and form | Class | Manufacturer | Reg. |
|---|---|---|---|---|
| Carbitol-400 ER | 400 mg Extended Release Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 1 |
| Convulyf | 200 mg Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 1 |
| Diamazepine | 200 mg Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 1 |
| Epazin | 200 mg Tablet | Rx | Torrent Pharmaceuticals Ltd. (India) | 1 |
| Epizipine | 200 mg Extended-Release Tablet; 400 mg Extended Release Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 2 |
| Lestremor | 200 mg Tablet | Rx | Flamingo Pharmaceuticals Ltd. (India) | 1 |
| Mazipine | 200 mg Tablet | Rx | Sai Mirra Innopharm Pvt. Ltd (India) | 1 |
| Medizepine 200 | 200 mg Tablet | Rx | Umedia Laboratories Pvt. Ltd. (India) | 1 |
| Mezacar | 200 mg Tablet | Rx | Kusum Healthcare Pvt. Ltd. (India) | 1 |
| Retagral | 200 mg Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 1 |
| Tegrepin | 200 mg Tablet | Rx | Intas Pharmaceuticals Limited (India) | 1 |
| Tegretol | 100 mg/5 mL Suspension; 200 mg Tablet | Rx | Delpharm Huningue SAS (France) +1 more | 2 |
| Tegretol LA | 400 mg Long Acting Film-Coated Tablet | Rx | Novartis Farma S.p.A. (Italy) | 1 |
| Tegretol SR | 200 mg Sustained Release Tablet | Rx | Novartis Farma S.p.A. (Italy) | 1 |
| Zemacarm | 200 mg Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) | 1 |
| No brand (generic) | 200 mg Extended Release Tablet; 200 mg Extended-Release Tablet; 200 mg Tablet | Rx | Stallion Laboratories Pvt. Ltd. (India) +2 more | 6 |
Source: FDA Philippines product registry, checked 2026-11-05. Look up any registration number at verification.fda.gov.ph.
Official leaflets
The package insert (PI) and patient leaflet (PIL) filed with FDA Philippines. Doses, side effects and warnings are there, written by the maker and approved by FDA.
- Carbastal: package insert (PI) (DRP-4013-02)
- Carbazedin: package insert (PI) (DRP-4013-03)
- Carbazedin ER: package insert (PI) (DRP-6097-02)
- Carbitol-200 ER: package insert (PI) (DRP-6097)
- Carbitol-400 ER: package insert (PI) (DRP-6098)
- Diamazepine: package insert (PI) (DRP-4013-01)
- Tegretol: package insert (PI) (DRP-7464)
- Tegretol: package insert (PI) (DRP-7452)
Paying less for carbamazepine
- Ask for the generic
Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works
- Senior or PWD card
20% off plus no VAT on your own medicines, with ID and prescription. What to bring
- No VAT on this one
It is on the FDA VAT-exempt list, so the 12% VAT should not be on your receipt. The list
Questions people ask
Do I need a prescription for carbamazepine in the Philippines?
FDA Philippines classifies carbamazepine as a prescription (Rx) medicine. A pharmacist may dispense it only against a valid prescription (Pharmacy Act, RA 10918).
Is there a generic carbamazepine registered in the Philippines?
FDA Philippines lists 31 registered carbamazepine products (checked 2026-11-05): 6 sold under the generic name only and 25 under 23 brand names. Ask the pharmacist for the unbranded generic: same ingredient and strength.
How much does carbamazepine cost in the Philippines?
The DOH Drug Price Reference Index, June 2024 edition, lists carbamazepine 200 mg tablet at a median of ₱2.25 (range ₱1.50 to ₱4.00). That is what public hospitals pay; drugstore prices are usually higher.
Where can I buy carbamazepine legally?
From an FDA-licensed drugstore or botika; the licence to operate (LTO) should be displayed in the store. Bring your prescription. Check that the box carries a DR- registration number, and be careful with online sellers that are not licensed pharmacies.
Is carbamazepine over the counter in the Philippines?
No. FDA Philippines lists all registered carbamazepine products, including 200 mg tablets and 200 mg and 400 mg extended-release tablets, as prescription (Rx) drugs.
Should carbamazepine be taken with food?
Yes. The label says to take it with meals.
Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.